The recent financial crisis OTC derivatives into the limelight as a leading cause of systemic risk. Governments and regional regulators world over have swung into action, pushing through landmark changes to improve regulatory and supervisory knowledge as well as counterparty transparency and protection. To this end, Europe’s new markets regulator, European Securities and Markets Authority (Esma) is driving the implementation of the European Commission’s regulatory reforms to OTC derivatives markets, in tandem with similar moves in the US under the Dodd-Frank Act.
As the consultation process continues on both sides and implementation deadlines loom on both sides of the Atlantic, questions abound as to the eventual scope and details of the reforms amongst all those likely to be impacted. In this complex and fast changing regulatory environment, it is essential that all actors in the OTC derivatives arena are on top of current legislative trends as well as the necessary operational next steps towards maximising risk management, financial flexibility and effective safeguarding of assets and capital, whilst minimising your costs at the same time.
C5’s EU OTC Derivatives and Clearing 2011 is a unique conference which will provide all market participants with in depth guidance on the new rules and also discussions, valuable insights and viewpoints from both regulators and buy and sell side market participants.
